A detailed history of Brown, Lisle/Cummings, Inc. transactions in Illumina, Inc. stock. As of the latest transaction made, Brown, Lisle/Cummings, Inc. holds 25 shares of ILMN stock, worth $3,503. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25
Previous 25 -0.0%
Holding current value
$3,503
Previous $2.61 Million 24.9%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 17, 2024

BUY
$101.05 - $133.57 $1,313 - $1,736
13 Added 108.33%
25 $2.61 Million
Q3 2023

Jun 28, 2024

SELL
$128.91 - $192.44 $12,891 - $19,244
-100 Reduced 89.29%
12 $1.65 Million
Q4 2022

Jun 28, 2024

BUY
$187.24 - $242.74 $2,246 - $2,912
12 Added 12.0%
112 $22.6 Million
Q4 2021

Jun 28, 2024

BUY
$347.28 - $421.83 $34,728 - $42,183
100 New
100 $38 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Brown, Lisle/Cummings, Inc. Portfolio

Follow Brown, Lisle/Cummings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown, Lisle/Cummings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Brown, Lisle/Cummings, Inc. with notifications on news.